跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Beludan-4 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Beludan-4
Approved
STANDARD
Beludan-4
Hiral Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
aa3cbfe0ab676b8f
Company
Hiral Labs Limited
Type
Standard
Approval Details
Approval Id
aa3cbfe0ab676b8f
Drug Approval Philippines Name
Beludan-4
Product Name
Beludan-4
Registration Number
DRP-15883
Brand Name
Beludan-4
Generic Name
Ondansetron hydrochloride
Dosage Form
Solution for Injection (I.M./I.V.)
Dosage Strength
4 mg/mL
Manufacturer
Hiral Labs Limited
Issuance Date
25 September 2024
Expiry Date
25 September 2029
Pharmacologic Category
Anti-emetic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
aa3cbfe0ab676b8f
Type
Standard
Back to Philippines FDA Approvals